Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2018, Sept. 21-25 in San Diego. Results demonstrated excellent efficacy and safety performance of the Virtue Sirolimus-Eluting Balloon (SEB) in a very challenging patient population with predominantly long, diffuse restenosis lesions within stents that had been implanted an average of nearly four years prior to the study enrollment.

Five-month-old Jack Palmer is home with his family in Kansas City after undergoing an extremely rare heart-lung transplant at St. Louis Children’s and Washington University Heart Center in May. At five months of age, Jack was the youngest patient to undergo this surgery successfully in more than a decade.

Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation (FMR). The data was presented at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, Sept. 21-25 in San Diego.

 New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, reinforce the safety, durability and consistency of the In.Pact Admiral drug-coated balloon (DCB) in real-world patients with peripheral arterial disease (PAD). Three-year real-world results from the full clinical cohort of the IN.PACT Global Study and one-year data from the Total IN.PACT pooled imaging and propensity analyses were presented at the TCT conference and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting, Sept. 22-26 in Lisbon, Portugal, respectively.

Corindus Vascular Robotics Inc. announced the first live transmission of a remote interventional procedure using the company’s CorPath platform was performed at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego on Sept. 22, 2018. The remote interventional procedure was broadcast live from Mayo Clinic to the TCT Main Arena. Utilizing CorPath GRX with developmental remote technology, combined with a telecommunications system to enable communication with the bedside staff, the operator at Mayo Clinic had the ability to remotely manipulate interventional devices within a porcine model's arteries while located in a different building.

September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of approximately 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp.

Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campaign. The campaign aims to increase awareness of strategies to help address acute kidney injury (AKI) following normal heart imaging procedures (angiograms) in patients with chronic kidney disease (CKD). As part of the campaign, Osprey Medical and GE Healthcare will sponsor a number of educational programs and seminars for healthcare professionals on how to address the risk of AKI.

At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers will showcase new products that span the continuum of care in cardiology. Introducing solutions in both the laboratory and imaging spaces, Siemens Healthineers will debut a new ultrasound real-time intra-cardiac echo (ICE) catheter and High-Sensitivity Troponin I assays. The company is also a sponsor of the Interventional Imaging and Endovascular Pavilions at TCT, supplying hands-on workshops and simulations for continuing education.

cardiologist Ted Feldman, M.D., at TCT 2017. #TCT2018 #TCT #TCT18 TCT Late breaking trials, studies.

October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clinical science presentations at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, which took place Sept. 21–25, 2018 at the San Diego Convention Center in California.

At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing its latest solutions in interventional cardiology. These solutions combine imaging systems, planning and navigation software, and specialized diagnostic and therapeutic devices, helping clinicians conduct procedures that are fast, efficient and personalized.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now